🔐 Secure Payment Guaranteed
Safe checkout with trusted global payment methods.
🌟 Why Choose Infinity Market Research?
At Infinity Market Research, we dont just deliver data — we deliver clarity, confidence, and competitive edge.
In a world driven by insights, we help businesses unlock the infinite potential of informed decisions.
Here why global brands, startups, and decision-makers choose us:
Industry-Centric Expertise
With deep domain knowledge across sectors — from healthcare and technology to manufacturing and consumer goods — our team delivers insights that matter.
Custom Research, Not Cookie-Cutter Reports
Every business is unique, and so are its challenges. Thats why we tailor our research to your specific goals, offering solutions that are actionable, relevant, and reliable.
Data You Can Trust
Our research methodology is rigorous, transparent, and validated at every step. We believe in delivering not just numbers, but numbers that drive real impact.
Client-Centric Approach
Your success is our priority. From first contact to final delivery, our team is responsive, collaborative, and committed to your goals — because you re more than a client; you re a partner.
Recent Reports
Global Wearable Massager Market
Global Dog Pepper Spray Market
Global GLP-1 for Diabetes Market Growth, Trends and Opportunities 2025-31
Jan 2026
Healthcare
Pages: 105
LPI50612
The global GLP-1 for Diabetes market size is predicted to grow from US$ 26760 million in 2025 to US$ 47290 million in 2031; it is expected to grow at a CAGR of 10.0% from 2025 to 2031.
Explore this report in detail? Download a free sample copy
Download Free Sample Report
GLP-1, or glucagon-like peptide-1, is a naturally occurring hormone in the body that plays a crucial role in glucose homeostasis. It is released from the intestine in response to food intake and stimulates the release of insulin from pancreatic beta cells. The primary function of insulin is to help cells in the body take up glucose, thereby lowering blood sugar levels.
Increasing Adoption of GLP-1 Receptor Agonists: GLP-1 receptor agonists were gaining popularity in the management of type 2 diabetes. These medications were recognized for their ability to improve glycemic control, stimulate insulin secretion, and offer potential benefits such as weight loss.
Development of New GLP-1 Therapies: Pharmaceutical companies were actively engaged in the research and development of new GLP-1 receptor agonists with improved formulations, longer durations of action, and enhanced patient adherence. This innovation aimed to provide more options for patients and healthcare providers.
Combination Therapies: The use of GLP-1 receptor agonists in combination with other classes of antidiabetic medications, such as SGLT-2 inhibitors or DPP-4 inhibitors, was explored to achieve better glycemic control and address multiple aspects of diabetes pathology.
Market Competition: The landscape for diabetes medications, including GLP-1 receptor agonists, was becoming more competitive. Competition often drives innovation and may lead to improved treatment options and cost-effectiveness.
Infinity Market Research newest research report, the GLP-1 for Diabetes Industry Forecast looks at past sales and reviews total world GLP-1 for Diabetes sales in 2024, providing a comprehensive analysis by region and market sector of projected GLP-1 for Diabetes sales for 2025 through 2031. With GLP-1 for Diabetes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 for Diabetes industry.
This Insight Report provides a comprehensive analysis of the global GLP-1 for Diabetes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GLP-1 for Diabetes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global GLP-1 for Diabetes market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 for Diabetes and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 for Diabetes.
This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 for Diabetes market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Injection
Oral Agent
Segmentation by Application:
Woman
Man
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.
Novo Nordisk
AstraZeneca
Eli Lily
GSK
Sanofi
Bristol-Myers Squibb
Amylin
Key Questions Addressed in this Report
What is the 10-year outlook for the global GLP-1 for Diabetes market?
What factors are driving GLP-1 for Diabetes market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do GLP-1 for Diabetes market opportunities vary by end market size?
How does GLP-1 for Diabetes break out by Type, by Application?
Global GLP-1 for Diabetes Market Scope
| Report Attribute | Details |
|---|---|
| Market Size (Start Year) | USD XX Million |
| Market Size (End Year) | USD XX Million |
| Compound Annual Growth Rate (CAGR) | USD XX Million |
| Forecast Period | USD XX Million |
| Base Year | USD XX Million |
| Historical Data | USD XX Million |
| Key Players | USD XX Million |
REPORT COVERAGE
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
SEGMENT COVERED
By component, deployment, organization size, application, and industry.
REGIONAL SCOPE
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
COUNTRY SCOPE
Includes key countries across all major regions.
📘 Frequently Asked Questions
1. What is the market size of Global Global GLP-1 for Diabetes Market?
Answer: The global GLP-1 for Diabetes market size is predicted to grow from US$ 26760 million in 2025 to US$ 47290 million in 2031; it is expected to grow at a CAGR of 10.0% from 2025 to 2031.
2. Which regions are analyzed in the Global Global GLP-1 for Diabetes Market report?
Answer: The Global Global GLP-1 for Diabetes Market report covers major regions such as Europe, Middle East & Africa. Each region is analyzed for trends, opportunities, and market dynamics.
3. What methodology is used for forecasting of Global Global GLP-1 for Diabetes Market?
Answer: The Global Global GLP-1 for Diabetes Market report uses a mix of primary research, secondary data, and expert analysis to build its forecasts. Models include both qualitative and quantitative approaches.
4. Are emerging markets analyzed separately in the Global Global GLP-1 for Diabetes Market?
Answer: Yes, the Global Global GLP-1 for Diabetes Market report highlights high-growth emerging regions with dedicated insights. These include untapped opportunities, risks, and potential for expansion.
5. Does the report include competitive benchmarking of Global Global GLP-1 for Diabetes Market?
Answer: Yes, Global Global GLP-1 for Diabetes Market report compares major players based on revenue, product portfolio, innovation, and regional presence. This helps assess competitive positioning.
6. Can I access country-level data within the Global Global GLP-1 for Diabetes Market report?
Answer: Yes, Global Global GLP-1 for Diabetes Market report includes detailed data by country, especially for key markets. This allows for localized insights and decision-making.
7. Can I get customized insights or data from the Global Global GLP-1 for Diabetes Market report?
Answer: Yes, we offer customization options to align with your specific business needs. You can request tailored sections or regional breakdowns.
🔐 Secure Payment Guaranteed
Safe checkout with trusted global payment methods.
🌟 Why Choose Infinity Market Research?
At Infinity Market Research, we dont just deliver data — we deliver clarity, confidence, and competitive edge.
In a world driven by insights, we help businesses unlock the infinite potential of informed decisions.
Here why global brands, startups, and decision-makers choose us:
Industry-Centric Expertise
With deep domain knowledge across sectors — from healthcare and technology to manufacturing and consumer goods — our team delivers insights that matter.
Custom Research, Not Cookie-Cutter Reports
Every business is unique, and so are its challenges. Thats why we tailor our research to your specific goals, offering solutions that are actionable, relevant, and reliable.
Data You Can Trust
Our research methodology is rigorous, transparent, and validated at every step. We believe in delivering not just numbers, but numbers that drive real impact.
Client-Centric Approach
Your success is our priority. From first contact to final delivery, our team is responsive, collaborative, and committed to your goals — because you re more than a client; you re a partner.
